⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001891053

Dalgleish Scott

Reports to the SEC for 1 company · CERRITOS, CA

Transactions

7

Companies

1

Filings

3

CIK

0001891053

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-21	STLNStarling Oncology, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+26.1K sh	—	—	26,062
2022-03-21	STLNStarling Oncology, Inc.A Award	Chief Financial Officer	AAward	+32.1K sh	—	—	151,008
2022-03-21	STLNStarling Oncology, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+163K sh	—	—	162,891
2021-11-12	STLNStarling Oncology, Inc. · Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+351K sh	—	—	350,876
2021-11-12	STLNStarling Oncology, Inc.A Award	Chief Financial Officer	AAward	+71.4K sh	—	—	118,916
2021-11-12	STLNStarling Oncology, Inc.A Award	Chief Financial Officer	AAward	+47.6K sh	—	—	47,566
2021-11-12	STLNStarling Oncology, Inc. · Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+261K sh	—	—	261,023

Recent filings

3

Accepted (ET)
Mar 294/A
Dalgleish Scott0001628280-22-007760
SEC(opens sec.gov)
Mar 234
Dalgleish Scott0001628280-22-007103
SEC(opens sec.gov)
Nov 164
Dalgleish Scott0001104659-21-140226
SEC(opens sec.gov)

Companies

1

Starling Oncology, Inc.Chief Financial OfficerSTLN

Address

C/O THE ONCOLOGY INSTITUTE INC. 18000 STUDEBAKER RD, SUITE 800

CERRITOS, CA, 90703